Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 87.60M | $ 24.00M | $ 71.10M | $ 40.90M | $ 109.20M |
Total Assets | $ 1.97B | $ 1.79B | $ 1.75B | $ 1.55B | $ 1.70B |
Total Debt | $ 679.20M | $ 655.20M | $ 654.20M | $ 704.40M | $ 744.50M |
Net Debt | $ 591.60M | $ 631.20M | $ 583.10M | $ 663.50M | $ 635.30M |
Total Liabilities | $ 1.48B | $ 1.34B | $ 1.33B | $ 1.23B | $ 1.33B |
Stockholders Equity | $ 488.00M | $ 450.60M | $ 420.30M | $ 321.10M | $ 375.50M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |